Vikas Gupta - Publications, H-index & Citations

Back

Vikas Gupta

medicine

75H-index

895Paper Count

2.5WCitation Count

Published Papers 118

Publication Date

Risk stratification of patients with TP53-mutated myeloproliferative neoplasms

Leukemia

IF13.4

2026-02-24

PREAI

Benjamin Rolles; Cilomar Martins de Oliveira Filho; Nathan Fergusson; Jan Philipp Bewersdorf; Julia Keating; Cecelia Perkins; Matthew Schwede; James England; Marlise R. Luskin; Daniel J. DeAngelo; Shai Shimony; Mifra Faiz; Addison C. Hillerbrand; Chulwoo Kim; Lachelle D. Weeks; Lauren Waldman; Mohammed Wazir; Joan How; Anna E. Marneth; Yiwen Liu; Martin J. Aryee; Raajit Rampal; Harrison K. Tsai; Jason Gotlib; Vikas Gupta; Maximilian Stahl; Ann Mullally

Save

JAK2V617F reprograms Hypoxia Inducible Factor-1 to induce a non-canonical hypoxia regulon in myeloproliferative neoplasms

Leukemia

IF13.4

2026-02-02

OAAI

David Kealy; Ruth Ellerington; Suraj Bansal; Jessie J. F. Medeiros; Catherine A. Hawley; Andy G. X. Zeng; Jakub Lukaszonek; Katie A. West; Aparna D. Sinha; Gillian Caalim; Richard T. Gawne; Jacob Pope; Bianca Lima Ferreira; Nicole-Mae Blacknell; Bryce Drylie; Jenny Chatzigerou; Hwei Minn Khoo; Adam C. Wilkinson; Adele K. Fielding; Guanlin Wang; Bethan Psaila; David G. Kent; Ian S. Hitchcock; Andrew N. Holding; Andrew S. Mason; Vikas Gupta; John E. Dick; Katherine S. Bridge

Save

A Stem and Progenitor Cell-Derived Gene Expression Signature is Prognostic for Survival in Myelofibrosis

Blood

IF23.1

2026-01-06

OAAI

Jessie J.F. Medeiros; Andy G.X. Zeng; Suraj Bansal; Hyerin Kim; Michelle Chan-Seng Yue; Tristan Woo; Jessica L. McLeod; Sagar Kothari; Andrea Arruda; Hubert Tsui; Jaime O. Claudio; Dawn Maze; Hassan Sibai; Mark D. Minden; James A. Kennedy; Christopher Famulare; Raajit K. Rampal; Jean C.Y. Wang; John E. Dick; Vikas Gupta

Save

Real-world experience with CPX-351 for secondary acute myeloid leukaemia: Comparison with FLAG-IDA in a propensity score matching analysis

BRITISH JOURNAL OF HAEMATOLOGY

IF3.8

2025-12-01

OAAI

Perusini, Maria Agustina; Patino, Ana Flavia; Andrews, Claire; Assouline, Sarit E.; Brandwein, Joseph M.; Chow, Signy; Popradi, Gizelle; Sanford, David; Savoie, Lynn; Saini, Lalit; Nadia, Bambace; Khalaf, Dina; Schuh, Andre C.; Yee, Karen; Gupta, Vikas; Maze, Dawn; Chan, Steven M.; Schimmer, Aaron D.; Sabry, Waleed; Sibai, Hassan

Save

What is the prognostic relevance of responses less than a CR to initial AML treatment?

Clinical Lymphoma Myeloma and Leukemia

IF2.7

2025-10-24

PREAI

Akhil Rajendra; Elliot Smith; Eshetu G. Atenafu; Aniket Bankar; Steven Chan; Marta Davidson; Vikas Gupta; Mark D. Minden; Maria Agustina Perusini; Guillaume Richard-Carpentier; Aaron Schimmer; Andre C. Schuh; Hassan Sibai; Karen Yee; Dawn Maze

Save

Defining remission following hematopoietic cell transplant for myelofibrosis: an international expert panel consensus

Leukemia

IF13.4

2025-10-13

PREAI

Rachel B. Salit; Elizabeth O. Hexner; Nico Gagelmann; Nicolaus Kröger; Donal P. McLornan; Tania Jain; Vikas Gupta; Gabriela S. Hobbs; Roni Tamari; Marie Robin; Bart Scott; Wael Saber

Save

Enasidenib plus venetoclax in patients with IDH2-mutated relapsed or refractory acute myeloid leukaemia or myelodysplastic syndrome (ENAVEN-AML): a multicentre, single-arm, phase 1b/2 trial

The Lancet Haematology

IF0

2025-10-08

PREAI

Guillaume Richard-Carpentier; Gopila Gupta; Charina Koraksic; Severine Cathelin; Lisa Wang; Aniket Bankar; Marta Davidson; Vikas Gupta; Dawn Maze; Mark D Minden; Tracy Murphy; Aaron D Schimmer; Andre C Schuh; Hassan Sibai; Karen Yee; Courtney D DiNardo; Joseph Brandwein; Caroline J McNamara; Steven M Chan

Save

Who truly benefits from gilteritinib combinations in FLT3-mutated relapsed-refractory(R/R) AML: a Canadian single center analysis

Blood Cancer Journal

IF11.6

2025-08-26

OAAI

Akhil Rajendra; Elliot Smith; Maria Agustina Perusini; Kenny Tang; Eshetu G. Atenafu; Aniket Bankar; Steven Chan; Marta B. Davidson; Vikas Gupta; Dawn Maze; Mark D. Minden; Guillaume Richard-Carpentier; Aaron D. Schimmer; Andre C. Schuh; Karen Yee; Hassan Sibai

Save

ADORE: an open platform study of ruxolitinib in combination with other novel therapies in patients with myelofibrosis

Blood Advances

IF7.1

2025-05-09

OAAI

David M. Ross; Florian H. Heidel; Andrew Charles Perkins; Andreas Reiter; Carl Crodel; Caroline Riley; María Teresa Gómez-Casares; Istvan Takacs; Heiko Becker; Thomas Lehmann; Olga Vinogradova; Kate Burbury; Alessandro M. Vannucchi; Vikas Gupta; Marielle Wondergem; Jean-Jacques Kiladjian; Grace Cleary; Angela Zhang; Jagannath Kota; Anirudh Prahallad; Monika Wroclawska; Min Lu; Claire N. Harrison

Save

Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial

NATURE MEDICINE

IF50

2025-03-10

OAAI

Rampal, Raajit K.; Grosicki, Sebastian; Chraniuk, Dominik; Abruzzese, Elisabetta; Bose, Prithviraj; Gerds, Aaron T.; Vannucchi, Alessandro M.; Palandri, Francesca; Lee, Sung-Eun; Gupta, Vikas; Lucchesi, Alessandro; Oh, Stephen T.; Kuykendall, Andrew T.; Patriarca, Andrea; alvarez-Larran, Alberto; Mesa, Ruben; Kiladjian, Jean-Jacques; Talpaz, Moshe; Scandura, Joseph M.; Lavie, David; Harris, Morgan; Kays, Sarah-Katharina; Li, Qing; Boxhammer, Rainer; Brown, Barbara; Jegg, Anna-Maria; Harrison, Claire N.; Mascarenhas, John

Save

Odyssey: A Phase 2 Open-Label Study of Momelotinib in Combination with Luspatercept in Patients with Transfusion-Dependent Myelofibrosis

BLOOD

IF23.1

2024-11-05

PREAI

Bose, Prithviraj; Gerds, Aaron T.; Gupta, Vikas; Strouse, Bryan; Patel, Bharat; Ellis, Catherine; Harrison, Claire

Save

FLAG-IDA Plus Venetoclax in High-Risk Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia: The Princess Margaret Cancer Center Experience

BLOOD

IF23.1

2024-11-05

PREAI

Al-Shaibani, Eshrak; Davidson, Marta Beata; Bankar, Aniket; Chan, Steven M.; Sibai, Hassan; Maze, Dawn C.; Schimmer, Aaron; Minden, Mark D.; Yee, Karen; Gupta, Vikas; Schuh, Andre C.; Richard-Carpentier, Guillaume

Save

Updated Results from the Phase 3 Manifest-2 Study of Pelabresib in Combination with Ruxolitinib for Janus Kinase Inhibitor-Naive Patients with Myelofibrosis

BLOOD

IF23.1

2024-11-05

PREAI

Mascarenhas, John O.; Grosicki, Sebastian; Chraniuk, Dominik; Abruzzese, Elisabetta; Bose, Prithviraj; Gerds, Aaron T.; Vannucchi, Alessandro M.; Palandri, Francesca; Lee, Sung-Eun; Gupta, Vikas; Lucchesi, Alessandro; Oh, Stephen; Kuykendall, Andrew T.; Patriarca, Andrea; Alvarez-Larran, Alberto; Mesa, Ruben; Kiladjian, Jean-Jacques; Talpaz, Moshe; Harris, Morgan; Kays, Sarah-Katharina; Li, Qing; Brown, Barbara; Jegg, Anna-Maria; Harrison, Claire; Rampal, Raajit

Save

A Phase 1/2 Study of Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor, in Combination with JAK Inhibitors Ruxolitinib or Momelotinib in Patients with Myelofibrosis

BLOOD

IF23.1

2024-11-05

PREAI

Mascarenhas, John O.; Rampal, Raajit; El Chaer, Firas; Gupta, Vikas; Shimoda, Kazuya; Kiladjian, Jean-Jacques; Passamonti, Francesco; Bose, Prithviraj; Scandura, Joseph M.; Mesa, Ruben; Rein, Lindsay A. M.; Yuda, Junichiro; Ross, David M.; Devos, Timothy; Talpaz, Moshe; Hoffman, Ronald; Kabir, Sujan; Li, Zhonggai; Foulks, Jason M.; Ansaldo, Karen; Seki, Masataka; Peddagali, Vishnu; Shah, Jatin; Harrison, Claire

Save

What Is the Prognostic Relevance of Responses Less Than a CR(Sub-CR) to Initial AML Treatment?

BLOOD

IF23.1

2024-11-05

PREAI

Rajendra, Akhil; Smith, Elliot; Atenafu, Eshetu; Bankar, Aniket; Chan, Steven M.; Davidson, Marta Beata; Gupta, Vikas; Minden, Mark D.; Perusini, Maria Agustina; Richard-Carpentier, Guillaume; Schimmer, Aaron; Schuh, Andre C.; Sibai, Hassan; Yee, Karen; Maze, Dawn C.

Save

Genomic profiles and outcomes in de novo versus therapy-related core binding factor AML

BLOOD CANCER JOURNAL

IF11.6

2024-10-31

OAAI

Chiu, May; Schimmer, Aaron D.; Schuh, Andre C.; Bankar, Aniket; Richard-Carpentier, Guillaume; Sibai, Hassan; Yee, Karen; Davidson, Marta; Chan, Steven M.; Gupta, Vikas; Maze, Dawn

Save

Exhaled Breath Condensate Surveillance for Aspergillus in Acute Leukemia-a Pilot Trial

OPEN FORUM INFECTIOUS DISEASES

IF3.8

2024-09-24

OAAI

Bitterman, Roni; Arora, Simran; Ng, Chun Fai; Walti, Laura; Ahmad, Syed Zain; Safi, Toufik; Gupta, Vikas; Husain, Shahid

Save

Advances in Stem Cell Transplantation for Myelofibrosis

Current Hematologic Malignancy Reports

IF3.3

2024-09-06

PREAI

Akhil Rajendra; Vikas Gupta

Save

Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study

BLOOD ADVANCES

IF7.1

2024-08-14

OAAI

Jain, Tania; Estrada-Merly, Noel; Salas, M. Queralt; Kim, Soyoung; Devos, Jakob; Chen, Min; Fang, Xi; Kumar, Rajat; Andrade-Campos, Marcio; Elmariah, Hany; Agrawal, Vaibhav; Aljurf, Mahmoud; Bacher, Ulrike; Badar, Talha; Badawy, Sherif M.; Ballen, Karen; Beitinjaneh, Amer; Bhatt, Vijaya Raj; Bredeson, Christopher; Defilipp, Zachariah; Dholaria, Bhagirathbhai; Farhadfar, Nosha; Farhan, Shatha; Gandhi, Arpita P.; Ganguly, Siddhartha; Gergis, Usama; Grunwald, Michael R.; Hamad, Nada; Hamilton, Betty K.; Inamoto, Yoshihiro; Iqbal, Madiha; Jamy, Omer; Juckett, Mark; Kharfan-Dabaja, Mohamed A.; Krem, Maxwell M.; Lad, Deepesh P.; Liesveld, Jane; Malki, Monzr M. Al; Malone, Adriana K.; Murthy, Hemant S.; Orti, Guillermo; Patel, Sagar S.; Pawarode, Attaphol; Perales, Miguel-Angel; van der Poel, Marjolein; Ringden, Olle; Rizzieri, David A.; Rovoa, Alicia; Savani, Bipin N.; Savoie, Mary Lynn; Seo, Sachiko; Solh, Melhem; Ustun, Celalettin; Verdonck, Leo F.; Wingard, John R.; Wirk, Baldeep; Bejanyan, Nelli; Jones, Richard J.; Nishihori, Taiga; Oran, Betul; Nakamura, Ryotaro; Scott, Bart; Saber, Wael; Gupta, Vikas

Save

Myelofibrosis management in routine clinical practice with a focus on patients with cytopenias: recommendations from a global consensus group

LEUKEMIA

IF13.4

2024-07-09

OAAI

Koschmieder, Steffen; Bose, Prithviraj; Ellis, Martin H.; Gupta, Vikas; Kiladjian, Jean-Jacques; Mascarenhas, John; Mathews, Vikram; Passamonti, Francesco; Harrison, Claire

Save

Research Directions